AWM
NVCR icon

Activest Wealth Management’s NovoCure NVCR Stock Holding History

Activest Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32
Closed -$727 – 1139
2024
Q4 		$954 Hold
32
– – ﹤0.01% 468
2024
Q3 		$500 Hold
32
– – ﹤0.01% 486
2024
Q2 		$548 Hold
32
– – ﹤0.01% 456
2024
Q1 		$500 Hold
32
– – ﹤0.01% 344
2023
Q4 		$478 Hold
32
– – ﹤0.01% 302
2023
Q3 		$517 Hold
32
– – ﹤0.01% 313
2023
Q2 		$4.88K Buy
+32
New +$1.99K ﹤0.01% 233

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Activest Wealth Management's NVCR Position: Q1 2025 in Review

Activest Wealth Management sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 32 shares — an estimated $727 sold.

Activest Wealth Management first reported a position in NVCR in Q2 2023 and held it in 7 quarters. The position peaked at $4.88K in Q2 2023. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • Activest Wealth Management reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • Activest Wealth Management sold 32 NovoCure shares in Q1 2025, an estimated $727.
  • Activest Wealth Management first reported a position in NovoCure in Q2 2023 and held it in 7 quarters.
  • Activest Wealth Management's NovoCure position peaked at $4.88K in Q2 2023.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on Activest Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.